Startup Valuation: How to Value Your Company

Valuation is one of the most misunderstood topics in the startup world. Founders obsess over it. Investors debate it. And neither side fully agrees on how it should work — because at the early stages, startup valuation is as much art as it is science.

Here is the reality: if your company has no revenue, no customers, and no product, your valuation is essentially a negotiation between what you believe you are worth and what the market is willing to pay. There are frameworks and benchmarks that guide that negotiation, but there is no formula that spits out a "correct" number. As a 3x founder who has been on both sides of this negotiation and an investor with 65+ investments, I have seen how valuation works in practice — not just in theory.

This guide covers everything you need to understand: the terminology, the methods, the benchmarks by stage, and the psychology of how VCs actually think about pricing your company.

1. Why Valuation Matters (And Why It Does Not)

Valuation matters because it determines how much of your company you give away in exchange for capital. A $5M pre-money valuation with a $1M raise means you give up ~17% of your company. A $10M pre-money with the same raise means you give up ~9%. Over multiple rounds, these differences compound significantly — the dilution at your seed round affects your ownership at Series A, B, and beyond.

But here is where founders go wrong: they treat valuation as a scorecard. "My startup is valued at $20M" feels like a validation of their idea, their team, and their potential. It is not. Valuation at the early stage is a bet on future potential, not a measure of current value. A high valuation is only good if you can grow into it. If you cannot, you have set yourself up for a painful down round or a flat round that demoralizes everyone.

2. Pre-Money vs. Post-Money Valuation

These two terms confuse more founders than any other concept in venture capital. Let us clear it up once and for all.

Here is a concrete example: if your pre-money valuation is $8M and an investor puts in $2M, your post-money valuation is $10M. The investor now owns $2M / $10M = 20% of the company.

Another example with different numbers: $4M pre-money, $1M investment, $5M post-money. The investor owns 20%. Notice that the percentage dilution is the same even though the absolute numbers are different — what matters is the ratio.

A critical nuance that trips up founders: when you are negotiating with a SAFE or convertible note that uses a post-money valuation cap (which is the YC standard SAFE), the option pool and all outstanding SAFEs are included in that cap. This means your effective dilution can be higher than you expect. Always model out your cap table with the actual terms, not just the headline number. Our fund benchmarking tools can help you understand what is typical at each stage.

3. Valuation Methods

There are several frameworks for valuing early-stage startups. No single method is definitive — in practice, VCs use a combination of approaches and a healthy dose of judgment.

A. Comparable Company Analysis

This is the most common approach: look at what similar companies raised at similar stages and use those data points as benchmarks. "Company X, which is at a similar stage in a similar market, raised at a $12M pre-money" is a powerful anchoring data point.

The challenge is finding truly comparable companies. Stage, market, traction, team, and geography all affect valuation. A SaaS company in San Francisco raising at seed will typically command a higher valuation than a similar company in a smaller market. Use data from platforms like PitchBook, Crunchbase, and our SaaS Valuations dashboard and AI Valuations dashboard to build your comp set.

B. Discounted Cash Flow (DCF)

DCF models project future cash flows and discount them back to present value. In theory, this is the most rigorous approach. In practice, it is nearly useless for early-stage startups because the inputs — future revenue, growth rates, margins, discount rates — are all guesses. A tiny change in any assumption produces wildly different outputs.

DCF becomes more relevant at Series B and beyond, where you have meaningful revenue and some predictability. At pre-seed and seed, it is an intellectual exercise at best.

C. Scorecard Method

Developed by angel investor Bill Payne, the scorecard method compares your startup across several dimensions against the "average" startup in your region and stage, then adjusts valuation up or down accordingly.

For each factor, you rate the startup relative to average (e.g., team is 1.2x average, market is 0.9x average). Multiply each factor by its weight, sum them up, and apply that multiplier to the average pre-money valuation for your region and stage. It is not precise, but it provides a structured way to think about relative value.

D. Berkus Method

The Berkus method, created by angel investor Dave Berkus, assigns a dollar value (up to $500K each) to five key risk-reduction milestones:

1. Sound idea (basic value, addresses risk): up to $500K
2. Prototype (reduces technology risk): up to $500K
3. Quality management team (reduces execution risk): up to $500K
4. Strategic relationships (reduces market risk): up to $500K
5. Product rollout or sales (reduces financial risk): up to $500K

This gives a maximum pre-money valuation of $2.5M for a pre-revenue company. It is most applicable at the earliest stages and provides a floor for thinking about value.

4. Valuation by Stage (2026 Benchmarks)

While every deal is different, here are the typical valuation ranges I am seeing in the current market. These numbers reflect U.S. startups and vary by geography, sector, and market conditions.

These ranges are broad because valuation is driven by many factors. A pre-seed AI company with a strong technical founder from Google DeepMind will command the top of the range. A first-time founder with a slide deck and no product will be at the bottom. For more on how stages differ, read our guide on pre-seed vs. seed vs. Series A.

5. Revenue Multiples for SaaS Companies

Once a startup has meaningful revenue, valuation shifts from qualitative assessment to multiple-based pricing. For SaaS companies, the dominant metric is the revenue multiple — typically measured as enterprise value divided by annual recurring revenue (ARR).

• Median SaaS multiple (2026): ~10-15x ARR for high-growth, venture-backed SaaS companies. This has compressed from the 2021 peak of 30-50x but remains healthy for companies with strong fundamentals.
• Growth premium: Companies growing 100%+ year-over-year command 20-30x+ ARR. Companies growing 50-100% sit in the 12-20x range. Below 50% growth, multiples drop to 5-10x.
• Net revenue retention: NRR above 120% is a strong positive signal and lifts multiples. It means existing customers are expanding faster than churning, which is the hallmark of a great SaaS business.
• Gross margins: SaaS companies with gross margins above 75% are valued at a premium. Companies with lower margins (especially those with significant services revenue) are discounted.

Track real-time SaaS multiples with our SaaS Valuations dashboard and see how AI companies compare with the AI Valuations dashboard.

6. How VCs Actually Think About Valuation

Here is the investor's perspective, which most founders do not understand. VCs are not trying to get the cheapest deal possible. They are trying to construct a portfolio where the winners return enough to cover the losers and generate strong fund-level returns. That means every investment needs a credible path to returning 10x or more.

The mental math works backwards:

1. What is the realistic exit value? If comparable companies in this space are acquired for $200-500M, that is the ceiling.
2. What ownership do I need at exit? After dilution from future rounds, the VC needs to own enough to make the return meaningful for the fund. For a seed investor who buys 15% and expects 50% dilution through Series A-C, they end up with ~7.5% at exit.
3. Does the math work? 7.5% of a $300M exit = $22.5M return. On a $2M seed check, that is ~11x. That works. On a $2M check at a $30M pre-money (getting only ~6% ownership), the diluted return drops to ~$13.5M or ~6.7x. That is borderline.

7. Negotiating Your Valuation

Valuation negotiation is a dance, and the best founders approach it with data, confidence, and flexibility.

• Anchor with data. Come to the table with comparable fundraises, your traction metrics, and a clear narrative about why you deserve the valuation you are asking for. "We want a $15M pre-money because similar companies with similar traction raised at that level" is much stronger than "We think we are worth $15M."
• Create competition. The single best way to get a good valuation is to have multiple interested investors. Run a disciplined fundraising process where you are talking to multiple firms simultaneously. Scarcity drives pricing.
• Focus on the total package. Valuation is one term among many. Pro-rata rights, board seats, liquidation preferences, anti-dilution provisions, and investor value-add all matter. A $12M pre-money with a great investor and clean terms is better than a $15M pre-money with onerous provisions.
• Know your walk-away number. Before you start negotiating, decide the minimum valuation you would accept. This prevents you from getting anchored down in the heat of negotiation. But be realistic — if the market is telling you a number, fighting it wastes everyone's time.
• Think about the next round. A sky-high seed valuation feels great today but creates pressure for your Series A. If you raise at $20M pre-money seed, you likely need a $60M+ pre-money Series A to avoid a flat or down round. Can you hit the milestones to justify that in 18 months?

8. Common Valuation Mistakes

After 65+ investments, I have seen every valuation mistake in the book. Here are the ones that come up most frequently:

1. Optimizing for the highest number. As discussed, a high valuation is not inherently good. It creates expectations, limits your investor options, and sets you up for potential down rounds.
2. Using top-down TAM as justification. "We are in a $100B market, so a $15M valuation is nothing" is not a valuation argument. It is a market size argument. They are different things.
3. Comparing to outliers. Yes, some companies raise at absurd valuations. They are the exception, not the rule. Comparing yourself to the top 1% of outcomes is a recipe for disappointment.
4. Ignoring dilution modeling. Most founders do not model their ownership through multiple rounds. If you do not understand how your 80% ownership at incorporation becomes 15% by Series C, you are negotiating blind.
5. Letting ego drive the conversation. Your company's valuation is not your personal worth. The founders who can separate their identity from the number negotiate better deals and build stronger investor relationships.

The Bottom Line

Startup valuation at the early stage is a negotiation informed by data, benchmarks, and market dynamics — not a precise science. The best founders understand the frameworks, know their numbers, and negotiate from a position of confidence and data.

Focus on building a company that justifies a premium valuation through strong traction, a great team, and a clear path to a large outcome. Use comp data from our SaaS Valuations and AI Valuations dashboards to ground your expectations. Understand your stage-specific benchmarks. And remember: the right valuation is one that allows you to raise enough capital, retain enough ownership, and partner with investors who will genuinely help you win.

The founders who build the biggest companies rarely had the highest valuations at seed. They had the right capital, the right partners, and the relentless execution to grow into (and far beyond) whatever number was on the term sheet.